Selinexor
IST: PRO5126
Phase 2 small_molecule terminated
Quick answer
Selinexor for Solid Tumor Malignancy is a Phase 2 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Solid Tumor Malignancy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated